Physician profile
Ted Parris
NPI 1336113828
$8,067.27
in general payments reported to CMS, 2019-2025
37 companies · $750 in 2025
The $750 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2020: $381 · 2021: $1,497 · 2022: $1,644 · 2023: $1,960 · 2024: $848 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,557.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,504.08 | 2019-2025 | Watchman Access System, General - Therapies |
| Impulse Dynamics (USA) INC. | $1,154.93 | 2021-2024 | Optimizer, Optimizer |
| Amgen INC. | $879.14 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $613.59 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $393.31 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $389.99 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $385.24 | 2019-2024 | Farxiga, Wainua |
| Pfizer INC. | $348.27 | 2019-2025 | |
| Abbott Laboratories | $287.44 | 2019-2023 | Xience Skypoint, Xience Sierra |
| Abiomed | $245.85 | 2022-2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.78 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $201.50 | 2021-2024 | Verquvo, Steglatro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $195.82 | 2019-2025 | Lifevest |
| Daiichi Sankyo INC. | $169.42 | 2019-2022 | |
| Novo Nordisk INC | $152.05 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $106.67 | 2021-2022 | |
| Medtronic, INC. | $106.55 | 2021-2023 | Onyx Frontier, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Shockwave Medical, INC | $82.30 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $78.21 | 2025 | Onpattro |
| Esperion Therapeutics, INC. | $53.87 | 2021-2024 | Nexletol |
| Atricure, INC. | $49.39 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $46.48 | 2019-2023 | |
| Biotronik INC. | $43.99 | 2019 | |
| Althera Pharmaceuticals LLC | $43.60 | 2021 | |
| Biosense Webster, INC. | $43.43 | 2021 | |
| Azurity Pharmaceuticals, INC. | $42.19 | 2023-2025 | Edarbi, Edarbi |
| Medicomp INC | $39.34 | 2019-2025 | Telepatch Cardiac Monitor |
| Takeda Pharmaceuticals U.S.A., INC. | $34.30 | 2025 | Livtencity |
| Lexicon Pharmaceuticals, INC. | $29.79 | 2023 | Inpefa |
| Akcea Therapeutics, INC. | $22.00 | 2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $20.97 | 2023 | Arcalyst |
| Preventice Services, LLC | $20.33 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.92 | 2020 | |
| Allergan, INC. | $14.45 | 2019 | |
| Medtronic Vascular, INC. | $11.27 | 2019 | |
| Terumo Medical Corporation | $10.84 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $8.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Parris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.